MBCI — MabCure Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.12m
- $0.50m
2007 December 31st | 2008 December 31st | R2009 December 31st | C2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.106 | 0.536 | 1.37 | 1.02 | 12.6 |
Operating Profit | -0.106 | -0.536 | -1.37 | -1.02 | -12.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.106 | -0.531 | -1.38 | -1.23 | -12.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.002 | -0.012 | -0.023 | -0.02 | -0.014 |
Dividends per Share |